免疫系统和癌症治疗的ubiquitination
Yizhou Du1, Huiyuan Zhang1, Hongbo Hu2,3
1Center for Immunology and Hematology, Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Advances in experimental medicine and biology
|November 15, 2024
概括
乌比基化是一种关键的蛋白质修饰,通过控制蛋白质稳定性和信号通路来调节免疫反应和癌症. 这篇评论探讨了它在天生的免疫力,T细胞激活和癌症免疫治疗中的作用.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 生物化学 生化学
- 癌症研究 癌症研究
背景情况:
- 乌比基因化是一种关键的翻译后修饰,调节各种细胞过程.
- 它通过蛋白质体降解和非降解信号控制蛋白质的稳定性和功能.
- 乌比基因化对于维持免疫常态稳定和调节先天性和适应性免疫都至关重要.
研究的目的:
- 审查最近在了解无处不在在免疫反应中的作用方面取得的进展.
- 为了突出ubiquitination对Toll-like受体信号传递在先天免疫中的影响.
- 讨论ubiquitination在T细胞激活,TCR信号传递和癌症免疫治疗中的作用.
主要方法:
- 最近科学出版物的文献综述.
- 对涉及免疫和癌症中无处不在的信号通路的分析.
- 专注于托尔类受体,T细胞激活和瘤免疫疗法机制.
主要成果:
- 乌比基提尼关键调节免疫细胞功能和炎症反应.
- 非降解性无处不在调节关键信号蛋白的活性和定位.
- 乌比基因化影响瘤抑制和促进,影响癌症的进展.
结论:
- 乌比基因化是免疫信号和细胞过程的中央调节者.
- 准无处不在的途径为免疫障碍和癌症提供了潜在的治疗策略.
- 对ubiquitination复杂作用的进一步研究对于推进免疫疗法和癌症治疗至关重要.
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Proteasome
815
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
815


